Table 1. Approved drugs and commonly used dosages for treatment of chronic HCV infection. [Download PDF]

 

Drug

Trade name (manufacturer)

Commonly used dosages

Interferon alfa-2a

  • Roferon (Roche)

3 million units 3 times per week

Interferon alfa-2b

  • Intron A (Schering-Plough)

3 million units 3 times per week

Interferon alfacon-1

  • Infergen (Intermune)

9-15 mcg 3 times a week

Ribavirin

  • Rebetol (Schering-Plough)
  • Copegus (Roche)

800 – 1200 mg per day

Peginterferon alfa-2a        

  • Pegasys (Roche)

1.5 mcg/kg weekly

Peginterferon alfa-2b

  • PEG-Intron (Schering-Plough)

180 mcg weekly

 

The dosages are provided for information purposes only.  Health care providers are advised to familiarize themselves with these drugs usage, dosages and adverse events, including dose-related toxicities, as provided in the package inserts of each drug.